2022 AAMD Plan Study Results

July 15, 20228 minute read

Prologue

The results of the 2022 AAMD Plan Study were recently presented at the AAMD’s annual meeting in Baltimore, Maryland by this year’s clinical organizers, Andrew Lin, CMD of Northwell Health and David Alicia, CMD of the Maryland Proton Treatment Center.

In this article you will find out how you can continue to learn from this study’s results, see a summary of some of the high performing individuals, and learn how to get involved in next year’s study.

Interactive Plan Library and Still-Active Scoring

Even though the submissions phase is over for this plan study, you can still use the technology to learn and improve. There are two main ways to continue to benefit from the 2022 event:

Interactive Library of Plans

If you were one of the 210 participants in this year’s event (i.e., you submitted a plan to the study), then you can peruse all of the submitted plans using the dedicated AAMD ProKnow site: https://aamd.proknow.com

All participants have been set up with an account for this site, and they merely need to sign in for the first time after which they will be able to navigate to the “2022 AAMD Plan Study: Results (Read-Only)” workspace to select individual plans and drill down to see dose distributions, scorecards, DVH curves, plan and beam parameters, and more. All plans in this read-only, interactive library have been anonymized.

Note: This will require a separate user account and login as the credentials you use for proknowsystems.com, but it only takes a few seconds to get started.

Continue Scoring New Plans

The plan study is still “live” for scoring new plans on the ProKnow Quality Systems platform. This is true even if you did not participate in the submissions phase of this plan study.

Simply sign in, go to the Organization: AAMD planning study library, and you will be able to score new plans, see the populations results, and learn from the experience of comparing your methods to your peers. You will not be able to submit a plan, but you can score as many different iterations as you want.

Results

Tables of high performers are shown below. Table 1 shows plans that received a high score (> 136) and also exhibited very efficient use of treatment beams (≤ 4) and total monitor units (< 5000). Table 2 shows photon plans in the top 33 percentile of all plans. Even though this specific study was focused on photon plans, several proton plans were submitted that also finished in the top 33 percentile of all scores, and these are shown in Table 3.

High-Performance, High-Efficiency

HIGH-PERFORMANCE, HIGH-EFFICIENCY (MU < 5000, # BEAMS ≤ 4, SCORE > 136)

Participant NameInstitutionModalityTPSScoreBeamsTotal MU
Anthony MartinGenesisCare-Myrtle Beach, SC (United States)VMATEclipse144.0234324
Thomas HeckerKlinikum Traunstein (Germany)VMATEclipse142.2344723
Jonathan StenbeckPrisma Health (United States)VMATEclipse141.9234233
Erin MurdochInova (United States)VMATRayStation141.4643878
Ryan PohlUniversity of Wisconsin-La Crosse (United States)VMATEclipse141.0533668
Jaroslava JanákováMasaryk Memorial Cancer Institute (Czech Republic)VMATEclipse140.8134656
Ahiko FumiyaElekta (Japan)VMATMonaco139.1834987
Peter TreonRhode Island Hospital (United States)VMATRayStation138.5243215
Angel MartinezElekta INCVMATMonaco136.9522730
Jacob HobergSCL Health (United States)VMATEclipse136.8544081
Kazuyuki UeharaKobe Minimally invasive Cancer Center (Japan)VMATEclipse136.0733888

Table 1. These participants excelled at producing not just a high score (score > 136) but also a very efficiency plan in terms of the number of beams (≤ 4) and total monitor units (< 5000).

High Scores, All Photon Plans

PHOTON PLANS: VMAT, IMRT, Helical, Robotic

Participant NameInstitutionModalityTPSScoreBeamsTotal MU
Simon HeinzeKantonsspital St.Gallen (Switzerland)VMATEclipse147.52916468
Friedemann HerberthKantonsspital St.Gallen (Switzerland)VMATEclipse146.98911798
lucas delbem albinoReal Hospital Portugues (Brazil)VMATEclipse145.7696092
Michael MastCommunity Health Network MDACC Kokomo (United States)VMATEclipse145.5888430
Thomas CostantinoCTSI / Instructor JPU (United States)VMATEclipse145.4448545
John DooleyAccuray, Inc. (United States)RoboticCyberKnife145.18
Matheus Fernando dos SantosReal Hospital Portugues (Brazil)VMATEclipse145.0245497
Vincent JostRaySearch Laboratories (Germany)VMATRayStation144.5469784
Gajendran NRegency Healthcare, Kanpur (India) (India)VMATEclipse144.1953025
Colin SimsAccurayRoboticCyberKnife144.07
Anthony MartinGenesisCare-Myrtle Beach, SC (United States)VMATEclipse144.0234324
Simon HeinzeKantonsspital St.Gallen (Switzerland)Helical ArcAccuray143.971
Keitt MobileElekta (United States)VMATMonaco143.6536575
Dustin Alex WhittingtonSelf Regional Healthcare (United States)VMATEclipse143.5847044
谢力Unreported (China)VMATMonaco143.4679022
Phillip MoloneyUniversity Hospital Geelong – ALCC (Australia)VMATEclipse143.4474263
Steven BoydElekta (United States)VMATMonaco143.3637126
Ryan ClarkVarian (United States)VMATEclipse143.0668188
Roman PioroMIOC (Uganda)VMATEclipse143.0187096
Rick VadenAccuray, Inc. (United States)RoboticCyberKnife142.781
Tanja WeissKlinikum Traunstein; Dep of Radiotherapy (Germany)VMATEclipse142.5955595
Simon HeinzeKantonsspital St.Gallen (Switzerland)VMATEclipse142.55612120
Patricia A MinyardElekta (United States)VMATMonaco142.3336135
DanilSCCOD (Russian Federation)VMATEclipse142.2677157
Thomas HeckerKlinikum Traunstein (Germany)VMATEclipse142.2344723
Tomas ProchazkaMasaryk Memorial Cancer Institute (Czech Republic)VMATEclipse142.2045911
Takeru AratoElekta (Japan)VMATMonaco142.0636900
MarcoASST Papa Giovanni XXIII – Bergamo (Italy)VMATEclipse141.95186870
Jonathan StenbeckPrisma Health (United States)VMATEclipse141.9234233
Dalibor LojkoNemocnica AGEL Komarno s.r.o. (Slovakia)VMATEclipse141.8867485
DeLee HoltAccuray (United States)Helical ArcAccuray141.861
Richard VadenAccuray (United States)Helical ArcAccuray141.731
Teresa PikeWinter Haven Hospital (United States)VMATEclipse141.7154965
Nick GeigerEmory Proton Therapy Center (United States)VMATEclipse141.6299254
Erin MurdochInova (United States)VMATRayStation141.4643878
Paul BarryElektaVMATMonaco141.4359045
Ryan PohlUniversity of Wisconsin- La Crosse (United States)VMATEclipse141.0533668
Argin G MikaeilianUCLA Medical center (United States)VMATEclipse141.0347982
Jaroslava JanákováMasaryk Memorial Cancer Institute (Czech Republic)VMATEclipse140.8134656
Yuuta MiyakeElekta (Japan)VMATMonaco140.3747238
Wong Wai LungPamela Youde Nethersole Hospital (Hong Kong)VMATEclipse140.041012621
Juan José Ferrero PedraQuironsalud (Spain)VMATMonaco139.9847677
Signe DuxSCL Health (United States)VMATEclipse139.9536095
Rick SchererElekta (United States)VMATMonaco139.8536848
Phil BowenAgnesian Cancer Center/SSM Health (United States)VMATPinnacle139.3773238
Michael ManteuffelMosaic Life Care (United States)VMATEclipse139.34412367
Mark BowersMoffitt Cancer Center (United States)VMATRayStation139.3054679
Ahiko FumiyaElekta (Japan)VMATMonaco139.1834987
Abriel HorakUC Davis Health System (United States)VMATRayStation138.9645585
PANG HELENPamela Youde Nethersole Eastern Hospital (Hong Kong)VMATEclipse138.9286240
Peter TreonRhode Island Hospital (United States)VMATRayStation138.5243215
SE YOUNG KIMYONSEI CANCER CENTER (South Korea)VMATRayStation138.4254337
Drew GranatowiczNebraska Medicine (United States)VMATEclipse138.3946838
Rui Silvakantonsspital (Portugal)VMATEclipse138.2146157
RonnieAuckland Radiation Oncology (New Zealand)VMATRayStation138.1769079
Fazal KhanMiami Cancer Institute (United States)VMATRayStation138.1452886
Joong-Yeol WooSheikh Khalifa Specialty Hospital (South Korea)VMATMonaco137.8526303
Matt SeithelElekta (United Kingdom)VMATMonaco137.7427212
Tomoyuki KurosawaElekta (Japan)VMATMonaco137.6647460
Dana SamsonHenry Ford Hospital (United States)VMATEclipse137.3845267
Mitchell TulchinskyNY Presbyterian Weill Cornell (United States)VMATEclipse137.2546048
praveenkumar nukasaniAmerican oncology institute (India)VMATEclipse137.1983820
David LyElekta (Australia)VMATMonaco137.1226256
Mattos Correvon TiffanyLa Source (Switzerland)VMATEclipse137.0256342
AngelElekta INCVMATMonaco136.9522730
Jacob HobergSCL Health (United States)VMATEclipse136.8544081
Katie JamiesonAndrew Love Cancer Centre (Australia)VMATEclipse136.2553283
Kazuyuki UeharaKobe Minimally invasive Cancer Center (Japan)VMATEclipse136.0733888

Table 2. These are the photon plans that achieved a score in the top 33 percentile of all submissions.

High Scores, Proton Submissions

PROTON PLANS

Participant NameInstitutionModalityTPSScoreBeams
Stephen ZieminskiMassachusetts General Hospital (United States)ProtonAstroid149.1812
Joseph VaughnUniversity of Kansas Cancer Center (United States)ProtonRayStation147.203
Nicolas DepauwMassachusetts General Hospital (United States)ProtonAstroid146.364
Lesley RosaVarian (United States)ProtonEclipse144.363

Table 3. Even though this specific study was focused on photon plans, several proton plans were submitted that also finished in the top 33 percentile of all scores.

Interested in Leading the 2023 AAMD Plan Study?

Each year, organizations like the AAMD run plan studies using the ProKnow Quality Systems platform. The plan studies are managed by clinical leaders who step forward help select the dataset, design plan and dose objectives, set the scoring rules, and prepare the conference presentation.

If you have ideas for the 2023 AAMD Plan Study and/or want to be part of the clinical planning team, please contact the AAMD to learn the next steps!